[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"renal-neoplasma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:renal-neoplasma":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":4,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100246520","phase-2-dc-vaccine-therapy-combined-with-cytokine-induced-killer-cell-in-treating-100246520",false,"NCT02487550","DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating","Inclusion Criteria:\n\n* Histologically proven renal cell carcinoma\n* Age: \\> 18\n* WHO- ECOG Performance Status 0-1\n* At least one measurable tumor lesions according to the RECIST criteria.\n* Life expectancy more than 3 months\n* Written informed consent\n\nExclusion Criteria:\n\n* Patients with a history of any other neoplastic disease less than 5 years ago (excepting treated carcinomas in situ of the cervix and basal\u002Fsquamous cell carcinomas of the skin).\n* Patients with metastatic disease in the central nervous system (CNS).\n* Patients with other significant illness including severe allergy, asthma, angina pectoris or congestive heart failure.\n* Patients with acute or chronic infection including HIV.\n* Patients who are pregnant or nursing.\n* Patients who have received antineoplastic therapy including chemotherapy or immunotherapy less than 4 weeks before beginning the trial.\n* Patients who receive corticosteroids or other immunosuppressive agents.\n* Patients with active autoimmune diseases such as lupus erythematosus, rheumatoid arthritis or thyroiditis.","ALL","18 Years","80 Years",{"count":19,"type":20},1200,"ESTIMATED","INTERVENTIONAL",[23],"PHASE2","The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.",[26],"Renal Neoplasma",[28,29],"Renal neoplasma","CIK cells","NOT_YET_RECRUITING","2015-06-29",{"date":33,"type":20},"2015-07-01",{"date":35,"type":4},"2015-08",{"date":37,"type":20},"2030-07",{"name":39,"class":40},"The First People's Hospital of Changzhou","OTHER"]